Author： Dragovich Tomislav Huberman Mark Hoff Daniel Rowinsky Eric Nadler Paul Wood Debra Hamilton Marta Hage George Wolf Julie Patnaik Amita
Publisher： Springer Publishing Company
ISSN： 0344-5704
Source： Cancer Chemotherapy and Pharmacology, Vol.60, Iss.2, 2007-07, pp. : 295-303
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
By Park Byeong-Bae Park Joon Lee Hyo Lee Jeeyun Choi Dong Choi Seong-Ho Heo Jin Lee Jong Lee Kyu Lim Do Park Young Lim Ho-Yeong Kang Won Park Keunchil
Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. :
Access to resources
Recommend
By Ko Andrew Venook Alan Bergsland Emily Kelley R. Korn W. Dito Elizabeth Schillinger Brian Scott Janet Hwang Jimmy Tempero Margaret
Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. :
Oncology Reports, Vol. 28, Iss. 3, 2012-01 ,pp. :
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
By Schelman William Morgan-Meadows Sherry Bailey Howard Holen Kyle Thomas James Eickhoff Jens Brandon Heidi Oliver Kate Alberti Dona Wilding George
Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. :
Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
By Song Hunho Han Boram Park Choong Kim Jong Jeon Jang Kim In-Gyu Kim Hyo Jung Joo Kim Jung Kwon Jung Jang Geundoo Kim Ho Kim Hyeong Choi Dae Zang Dae
Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. :